MARC ALLAN: Open Payments
NPI 1073043337 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $212 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $102 |
| ABBVIE INC. | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| PFIZER INC. | 2 | $37 |
| UCB, Inc. | 1 | $33 |
| Exact Sciences Corporation | 1 | $29 |
| Abbott Laboratories | 1 | $25 |
| Viatris Specialty LLC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $17 |
Products named: Rybelsus, Ozempic, LEQVIO, Bimzelx, VRAYLAR, Cologuard Collection Kit, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across ID — which companies pay providers there.
